ELENA REECE

Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Allergy/Immunology WASHINGTON, DC NPI 1619086667

General Payments — all program years on this page

$5,177.63

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 207
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $519.54 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $519.5414

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
GlaxoSmithKline, LLC. $186.965
Acerta Pharma LLC $160.763
UCB, Inc. $67.492
Regeneron Healthcare Solutions, Inc. $60.982
Genentech USA, Inc. $25.901
Phadia US Inc. $17.451

By program year

Program yearAmountRecords
2018 $631.4027
2019 $853.5233
2020 $374.6417
2021 $1,002.1144
2022 $1,080.3146
2023 $716.1126
2024 $519.5414

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1067578306 Phadia US Inc. $17.45 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104314096 AstraZeneca Pharmaceuticals LP $109.93 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105794126 AstraZeneca Pharmaceuticals LP $24.50 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105823875 AstraZeneca Pharmaceuticals LP $26.33 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114144969 Regeneron Healthcare Solutions, Inc. $30.44 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114144971 Regeneron Healthcare Solutions, Inc. $30.54 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116193438 GlaxoSmithKline, LLC. $21.80 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116321911 GlaxoSmithKline, LLC. $27.37 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116459805 GlaxoSmithKline, LLC. $8.08 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116543078 GlaxoSmithKline, LLC. $4.97 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116614334 GlaxoSmithKline, LLC. $124.74 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133005834 Genentech USA, Inc. $25.90 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143171694 UCB, Inc. $21.77 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143171696 UCB, Inc. $45.72 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.